Doccla, a leader in virtual hospital and remote patient monitoring services, has announced a major financial boost with a Series B funding round totaling £35 million. This substantial investment will facilitate the company’s strategic expansion into European markets.
Led by Lakestar, with contributions from Elaia and existing investors General Catalyst, Bertelsmann Investments, and Speedinvest, the funding underscores strong confidence in Doccla’s innovative business model. Lakestar Partner Oliver Heimes will join the Doccla board as part of this round.
The new capital will enable Doccla, headquartered in London, to strengthen its foothold in the UK and Ireland, where it is already making significant inroads. With operations in over ten European countries and collaborations with NHS Trusts across more than half of NHS regions, including a recent partnership with Ireland’s Health Service Executive (HSE), Doccla is poised for further growth. The focus will be on expanding into France and the DACH (Germany, Austria, and Switzerland) region, with potential plans for broader international reach.
Regulated by the Care Quality Commission (CQC) in England, Doccla provides 24/7 monitoring across 40 pathways, offering real-time patient data access and proactive care. This approach aims to reduce emergency admissions and alleviate patient stress by enabling early intervention.
Martin Ratz, Co-Founder of Doccla, remarked: “Our mission is to provide high-quality hospital-level care at home. With this funding, we can advance our European operations and explore opportunities in the Life Sciences sector, continuing to enhance patient care and optimize healthcare resources.”
Oliver Heimes of Lakestar added: “Doccla’s rapid ascent from a research project to a market leader in the UK is impressive. We are confident in their ability to replicate this success in new markets and expand their service offerings. The effectiveness of remote patient care is setting new standards globally.”
Editorial Perspective:
Doccla’s expansion is not just a step forward for the company but a significant advancement in the broader healthcare landscape. The integration of advanced remote monitoring technologies into everyday patient care represents a transformative shift towards more personalized and proactive healthcare. By enabling patients to recover in the comfort of their homes while maintaining high-quality oversight, Doccla is setting a new standard for patient-centered care.
The company’s growth into European markets and potential international expansion aligns with the broader trend of digital health innovations reshaping how care is delivered. With a proven track record and a clear vision for future development, Doccla is well-positioned to leverage its technology to address global healthcare challenges. This not only highlights the potential for enhanced patient outcomes but also reflects a growing recognition of the value of remote care solutions in modern healthcare systems.
The commitment to continuous investment in data science and technology further underscores Doccla’s dedication to refining its offerings and extending its impact. As the healthcare industry increasingly embraces digital solutions, Doccla’s leadership and innovation are likely to play a pivotal role in shaping the future of patient care.
